Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human DLK-1 ELISA Kit (AC2426)
Cat.#: ASET-1015
Specifications
Description Human DLK-1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human DLK-1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.47 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1344 Rat Dopamine Transporter ELISA Kit (AC2755) Quantitative inquiry ASET-2079 Mouse EGR2 ELISA Kit (AC3490) Quantitative inquiry ASET-1917 Human Leptin ELISA Kit (AC3328) Quantitative inquiry ASET-1878 Human NMDAR2B ELISA Kit (AC3289) Quantitative inquiry ASET-1210 Malondialdehyde ELISA Kit (AC2621) Quantitative inquiry ASET-1235 Human Cadherin 10 ELISA Kit (AC2646) Quantitative inquiry ASET-1181 Rat BACE1 ELISA Kit (AC2592) Quantitative inquiry ASET-2337 Human GLP1 ELISA Kit (AC3748) Quantitative inquiry ASET-1298 Guinea Pig Insulin ELISA Kit (AC2709) Quantitative inquiry ASET-2217 Human CCR5 ELISA Kit (AC3628) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket